LI-based Aceto begins selling drug to treat dry mouth
Aceto Corp. has begun selling a generic drug used to treat dry mouth, the Port Washington-based company announced.
The drug, cevimeline hydrochloride, is an alternative to the brand-name Evoxac from the Japanese pharmaceutical giant, Daiichi Sankyo Inc. The market for the generic is estimated to be about $56 million per year, according to the IMS Health data service.
Cevimeline hydrochloride is being sold by Aceto's Rising Pharmaceuticals division and is the fifth drug it has launched this year.
Updated 37 minutes ago Suozzi visits ICE 'hold rooms' ... U.S. cuts child vaccines ... Coram apartment fire ... Out East: Custer Institute and Observatory
Updated 37 minutes ago Suozzi visits ICE 'hold rooms' ... U.S. cuts child vaccines ... Coram apartment fire ... Out East: Custer Institute and Observatory
